Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000992681 | SCV000514233 | likely benign | not provided | 2020-01-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000542358 | SCV000630102 | likely benign | Progressive sclerosing poliodystrophy | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Wong Mito Lab, |
RCV000542358 | SCV000887225 | likely benign | Progressive sclerosing poliodystrophy | 2018-10-01 | criteria provided, single submitter | clinical testing | The NM_002693.2:c.1638C>T (NP_002684.1:p.Arg546=) [GRCH38: NC_000015.10:g.89326686G>A] variant in POLG gene is interpretated to be a Likely Benign based on ACMG guidelines (PMID: 25741868). This variant meets the following evidence codes reported in the ACMG-guideline. BP4:Computational evidence/predictors indicate no impact on the POLG structure, function, or protein-protein interaction. BP7:The variant is silent with non predicted splice impact. Based on the evidence criteria codes applied, the variant is suggested to be Likely Benign. |
Athena Diagnostics | RCV000992681 | SCV001145146 | likely benign | not provided | 2018-08-24 | criteria provided, single submitter | clinical testing |